Your browser doesn't support javascript.
loading
Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study.
Fancourt, Nicholas; Deloria Knoll, Maria; Baggett, Henry C; Brooks, W Abdullah; Feikin, Daniel R; Hammitt, Laura L; Howie, Stephen R C; Kotloff, Karen L; Levine, Orin S; Madhi, Shabir A; Murdoch, David R; Scott, J Anthony G; Thea, Donald M; Awori, Juliet O; Barger-Kamate, Breanna; Chipeta, James; DeLuca, Andrea N; Diallo, Mahamadou; Driscoll, Amanda J; Ebruke, Bernard E; Higdon, Melissa M; Jahan, Yasmin; Karron, Ruth A; Mahomed, Nasreen; Moore, David P; Nahar, Kamrun; Naorat, Sathapana; Ominde, Micah Silaba; Park, Daniel E; Prosperi, Christine; Wa Somwe, Somwe; Thamthitiwat, Somsak; Zaman, Syed M A; Zeger, Scott L; O'Brien, Katherine L.
Affiliation
  • Fancourt N; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Deloria Knoll M; Murdoch Children's Research Institute and.
  • Baggett HC; Royal Children's Hospital, Melbourne, Australia.
  • Brooks WA; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Feikin DR; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
  • Hammitt LL; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Howie SRC; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Kotloff KL; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
  • Levine OS; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Madhi SA; Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Murdoch DR; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Scott JAG; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Thea DM; Medical Research Council Unit, Basse, The Gambia.
  • Awori JO; Department of Paediatrics, University of Auckland and.
  • Barger-Kamate B; Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Chipeta J; Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine,Baltimore.
  • DeLuca AN; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Diallo M; Bill & Melinda Gates Foundation, Seattle, Washington.
  • Driscoll AJ; Medical Research Council, Respiratory and Meningeal Pathogens Research Unit and.
  • Ebruke BE; Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Higdon MM; Department of Pathology, University Otago and.
  • Jahan Y; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Karron RA; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Mahomed N; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom.
  • Moore DP; Center for Global Health and Development, Boston University School of Public Health, Massachusetts.
  • Nahar K; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Naorat S; Department of Pediatrics, Division of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Ominde MS; Spokane Emergency Physicians, Washington.
  • Park DE; Department of Paediatrics and Child Health, University of Zambia School of Medicine and.
  • Prosperi C; University Teaching Hospital, Lusaka, Zambia.
  • Wa Somwe S; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Thamthitiwat S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Zaman SMA; Centre pour le Développement des Vaccins (CVD-Mali), Bamako, Mali.
  • Zeger SL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • O'Brien KL; Medical Research Council Unit, Basse, The Gambia.
Clin Infect Dis ; 64(suppl_3): S262-S270, 2017 Jun 15.
Article in En | MEDLINE | ID: mdl-28575361
ABSTRACT
BACKGROUND. Chest radiographs (CXRs) are frequently used to assess pneumonia cases. Variations in CXR appearances between epidemiological settings and their correlation with clinical signs are not well documented. METHODS. The Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized World Health Organization (WHO)-defined severe and very severe pneumonia from 9 sites in 7 countries (Bangladesh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia). At admission, each case underwent a standardized assessment of clinical signs and pneumonia risk factors by trained health personnel, and a CXR was taken that was interpreted using the standardized WHO methodology. CXRs were categorized as abnormal (consolidation and/or other infiltrate), normal, or uninterpretable. RESULTS. CXRs were interpretable in 3587 (85%) cases, of which 1935 (54%) were abnormal (site range, 35%-64%). Cases with abnormal CXRs were more likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% vs 38%; all P < .05). CXR consolidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to other infiltrate (4.7%) or normal (4.9%) CXRs. CONCLUSIONS. Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to have signs typically associated with pneumonia. However, CXR-normal cases were common, and clinical signs considered indicative of pneumonia were present in substantial proportions of these cases. CXR-consolidation cases represent a group with an increased likelihood of death at 30 days post-discharge.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Radiography, Thoracic Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male / Newborn Country/Region as subject: Africa / Asia / Oceania Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Radiography, Thoracic Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male / Newborn Country/Region as subject: Africa / Asia / Oceania Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2017 Document type: Article